Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety. - Wikidata - awgldk - TriplyDB

Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety.

Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety.

http://www.wikidata.org/entity/Q37147931

about

Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery.Engineering of Botulinum Neurotoxins for Biomedical Applications.

P2860

Q37654972-2C6C9F49-0EE6-4903-B2A6-B18B7334209E Q55460011-1171C143-53E9-4F11-8C15-5AB1295FBA13

P2860

Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety.

http://www.wikidata.org/entity/Q37147931

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.

@en

Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.

@nl

type

label

Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.

@en

Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.

@nl

prefLabel

Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.

@en

Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.

@nl

P1433

Q37147931-E8FFDE7B-34DF-4630-B35D-2769390B022C

P1476

Q37147931-7D869B8B-0147-4804-99C2-60695521C52F

P2093

Q37147931-05E16B00-52D2-4D43-A0F3-7B4BF3E23A62

Q37147931-9A703E40-8273-4C50-9201-6954AC6D74A8

Q37147931-AC59284D-882B-4B26-811C-0B1C65DA0389

Q37147931-BE134504-69CF-4014-967E-79DCCEBEF092

Q37147931-E436D15C-4855-4C5E-AF51-D951765F25B2

Q37147931-FA5C643A-36AB-457A-AEC7-7F9508F576C5

P2860

Q37147931-011E1E7F-9225-4E86-9314-193E9163170F

Q37147931-05E49CBD-DED6-46FF-9882-34EA4FE8E683

Q37147931-0E77475F-8CD3-491C-ABF8-19164C678B92

Q37147931-0F7639A4-BA0C-4F7E-A02E-991E77773F62

Q37147931-3D723605-59BA-4F29-AE84-6EF3799C77FF

Q37147931-3F09F8C4-A5D3-43B2-AE3B-D958CCF3844C

Q37147931-AB0093AC-5CF5-4BA8-827E-9AF9EEE666DF

Q37147931-CFF8F722-4545-4AE2-9098-38A16AA5E942

Q37147931-D43126D0-B951-46F9-ABB3-3686BC434E34

Q37147931-D4D3121E-F468-4742-9FF8-750BC382D96C

P2888

Q37147931-C136345B-4B80-453E-A333-75E6F2B00AB7

P304

Q37147931-17C8A99E-2AC7-4276-8DFD-3F56F40AF255

P31

Q37147931-D770B6E0-515E-4550-8950-4329F467DC20

P356

Q37147931-E5B30DFD-F3C9-40C2-9AF9-145E4C4B157C

P407

Q37147931-7C59EBA6-6FD3-4F71-8FF1-9480D0AEFF25

P478

Q37147931-9745C338-A265-4028-849B-44245CB8F28B

P50

Q37147931-839F4924-0FE8-4E73-81BE-D1CC76780E1B

P577

Q37147931-30A2AA26-22F3-4E8C-8A9C-C3000DB9AF93

P6179

Q37147931-1A0ADE58-C6CE-4373-BA20-9F8441AE42D9

P698

Q37147931-BC961533-A685-4FF2-81CE-E6F1449FEED5

P932

Q37147931-378EB10B-B977-455E-814F-743C3CF97DD0

P356

P1433

Scientific Reports

P1476

Pre-Clinical Study of a Novel ...... ngineered for Improved Safety.

@en

P2093

Aurelia Syngkon

http://www.w3.org/2001/XMLSchema#string

Christopher Angeles

http://www.w3.org/2001/XMLSchema#string

Edwin Vazquez-Cintron

http://www.w3.org/2001/XMLSchema#string

Luis Tenezaca

http://www.w3.org/2001/XMLSchema#string

Philip Band

http://www.w3.org/2001/XMLSchema#string

Victoria Liublinska

http://www.w3.org/2001/XMLSchema#string

P2860

Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm

Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A.

Identification of the major steps in botulinum toxin action.

Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes.

Clinical applications of botulinum toxin.

Recombinant derivatives of botulinum neurotoxin A engineered for trafficking studies and neuronal delivery.

SV2 is the protein receptor for botulinum neurotoxin A.

Structure and function of tetanus and botulinum neurotoxins.

Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting.

Substrate recognition strategy for botulinum neurotoxin serotype A.

P2888

P304

30429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP30429

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Konstantin Ichtchenko

P577

2016-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044451645

http://www.w3.org/2001/XMLSchema#string

P698

27484492

http://www.w3.org/2001/XMLSchema#string

P932

4971498

http://www.w3.org/2001/XMLSchema#string